Weekly Round-Up June 27 to July 03
July 04, 2022
Private medical technology startup Centerline Biomedical announces the completion of a $33 million Series B equity fundraising sponsored by Cleveland Clinic. GE Healthcare, RIK Enterprises, JobsOhio, Jumpstart Ventures, and G2 Group Ventures participated in the financing. The company is a privately held medical technology business.
Cerby announced an additional $12 million in seed funding from Ridge Ventures, Bowery Capital, Okta Ventures, Salesforce Ventures to bring the total capital to $15.5 million. Cerby made its formal debut at the BlackHat Security Conference.
Clinical-stage pharmaceutical firm,Cerebral Therapeutics, which is developing novel treatments for neurological disorders, announced the closing of a $40 million Series C investment round.
Existing investors RA Capital Management, Perceptive Advisors, Vivo Capital LLC, and Granite Point Capital Management L.P. joined Lynx1 Capital Management in leading the round.
A $33 million investment round has been completed for the tech firm ‘Spot’, which offers on-demand accident insurance.
Spot has raised $33 million in capital, including $8 million in debt and $25 million in equity.
OppZo announced an investment for $260 million in debt and equity.
OppZo is a mission-driven financial technology firm that aims to provide access to capital for small and medium-sized businesses.
In order to increase human wellbeing and productivity in the digital age, TaskHuman, the 1:1 digital coaching platform, announced that it has raised $20 million in Series B funding.
Impact Venture Capital, RingCentral Ventures, Sure Ventures, USVP, and new investors Gaingels, PeopleTech Angels, Propel(x), and Zoom Ventures joined Madrona in leading the round. Hemant Thapar and Margo Georgiades are additional participating angel investors.
SAN FRANCISCO, CA, A cancer metabolism firm Faeth Therapeutics reported the fulfillment of a $47 million Series A round of private investment.
S2G Ventures led the investment, which brought the total funding to date to $67 million.
CAMBRIDGE, MA VistaPath, a supplier of solutions for data-driven pathology processing powered by artificial intelligence (AI), has raised $4 million in seed funding from investors including NextGen Venture Partners, First Star Ventures, and Moxxie Ventures.